We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
- Authors
Roozekrans, M; Olofsen, E; van der Schrier, R; van Gerven, J; Peng, S; McLeod, J; Dahan, A
- Abstract
Opioid-induced respiratory depression (OIRD) is a serious and potentially life-threatening complication of opioid overdose, abuse, and misuse. An option to avert OIRD is to treat patients on strong opioids with respiratory stimulants that do not interact with the opioid system and consequently do not compromise opioid analgesic efficacy. The BK-channel blocker GAL021 is a respiratory stimulant acting at K+-channels expressed on type 1 carotid body cells. The authors performed a population pharmacokinetic-pharmacodynamic (PKPD) analysis on the ability of GAL021 to reverse alfentanil-induced respiratory depression in 12 male volunteers using an isohypercapnic experimental design. The analysis showed that (1) GAL021 interacts in a multiplicative fashion with alfentanil and GAL021, which predicts that GAL021 efficacy is reduced at low ventilation levels; (2) GAL021 has a rapid onset/offset with a blood-effect site equilibration half-life not different from zero; and (3) GAL021 displays ceiling in its efficacy to reverse OIRD.
- Subjects
POTASSIUM antagonists; PHARMACOKINETICS; PHARMACODYNAMICS; OPIOID analgesics; ALFENTANIL; VENTILATION; THERAPEUTICS
- Publication
Clinical Pharmacology & Therapeutics, 2015, Vol 97, Issue 6, p641
- ISSN
0009-9236
- Publication type
Article
- DOI
10.1002/cpt.99